Restrictions on the use of cabergoline and those who should use it with caution

Cabergoline, as a dopamine receptor agonist, has been widely used to treat Parkinson's disease, hyperprolactinemia and other diseases. However, this drug is not suitable for everyone, and there are some clear contraindications for use and situations that require special caution. This article will introduce it in detail.

First of all, patients who are allergic to cabergoline or its components are absolutely prohibited from using this drug. Anaphylaxis can cause serious health problems and may even be life-threatening. Additionally, cabergoline should not be used in patients with uncontrolled high blood pressure or heart valve disease, as the drug may exacerbate these conditions and put the patient at greater risk.

At the same time, patients with tissue fibrosis in the lungs, heart or stomach, or patients with allergic reactions to ergot drugs (such as dihydroergotamine, ergotamine, etc.) should also avoid using cabergoline to prevent adverse reactions caused by the drug.

In addition to the above contraindications, there are certain groups of people who need to be particularly cautious when using cabergoline. Cabergoline may interact with other medications, especially those that have sedative effects (such as opioids, sleeping pills, etc.). Therefore, if patients are taking these medications, cabergoline should be used under the guidance of a physician to avoid the risk of potential drug interactions.

In addition, patients with abnormal liver function also need to be particularly careful when using cabergoline. Because cabergoline is primarily metabolized by the liver, abnormal liver function may affect the drug's metabolic process, thereby increasing the risk of drug accumulation in the body. In such patients, cabergoline should be monitored more closely.

In addition, the use of dopaminergic antiparkinsonian drugs, including cabergoline, is generally not recommended in patients with severe psychotic disorders because such drugs may worsen psychotic symptoms. Also, certain medications used to treat mental illness may reduce the effectiveness of cabergoline.

Overall, although cabergoline plays an important role in the treatment of certain conditions, its use must be based on a careful risk assessment based on the patient's specific circumstances. Patients should explain their health conditions and other medications they are taking to their doctors in detail before use to ensure the safety and effectiveness of the medication. Currently, cabergoline is available in various versions in overseas markets with different prices. Patients should choose the appropriate drug version according to their own needs. It should be noted that there are certain risks in purchasing drugs overseas. Please be sure to choose guaranteed overseas formal channels and pay attention to distinguishing the authenticity of the drugs.